Specrize Trademark Details

Specrize was registered on Tuesday, June 14, 2011 and is currently owned by Pfizer Inc. under the registration number 3979086 . This mark is alive with a status of Registered. The last case file activity for this mark occured 12 years ago on Tuesday, June 14, 2011, according to the United State Patent & Trademark Office
Word Mark Specrize
Status Alive Registered 700 — Registered
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 77951733
Registration Number 3979086
Status Date Tuesday, June 14, 2011
Filing Date Tuesday, June 14, 2011
Registration Date Tuesday, June 14, 2011
Attorney Cindy M. Zelson

Correspondent

CINDY M. ZELSON
PFIZER INC.
150 E 42ND ST
NEW YORK, NY 10017-5612

Case File Statements

Goods & Services Pharmaceutical preparations for the treatment of oncological diseases and disorders
Pseudo Mark Special Size

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Wednesday, March 10, 2010
First Use Anywhere Tuesday, March 15, 2011
First Use In Commerce Tuesday, March 15, 2011
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.